Linked to 567 companies since Mar 1995. A filing names it for 60% of those. The rest come from a text search, which also finds a firm on the other side of a deal.
These figures describe clients, not conduct. A lawyer or firm can serve many companies that later had trouble for reasons that have nothing to do with their work, and nothing here says any lawyer or firm did anything wrong.
41 of these companies later showed signs of SEC or DOJ scrutiny and had another red flag. Comparable companies would show 39.2, so that is 1.05× what you would expect.
Each bar’s tick marks 1×, no more than comparable companies. A colored bar has q below 0.05, the usual bar.
| What came later | Companies | Expected | × expected | q |
|---|---|---|---|---|
| SEC or DOJ scrutiny and another red flag | 41 | 39.2 | 1.05 | 1.000 |
| SEC or DOJ scrutiny | 54 | 58.7 | 0.92 | 1.000 |
| Stopped filing, and the SEC acted | 16 | 26.7 | 0.60 | 1.000 |
| Shares fell 95% from their high | 174 | 147.5 | 1.18 | 0.481 |
| Two or more different red flags | 152 | 123.3 | 1.23 | 0.074 |
| Said its accounts could not be relied on | 77 | 84.5 | 0.91 | 1.000 |
| Bankruptcy or receivership | 45 | 28.7 | 1.57 | 0.056 |
| Restructuring or accelerated debt | 181 | 127.2 | 1.42 | <0.001 |
| Delisting notice | 267 | 220.0 | 1.21 | 0.004 |
| SEC accounting enforcement release | 15 | 12.2 | 1.23 | 1.000 |
| An SEC release or DOJ statement names it, an officer or its stock | 33 | 32.0 | 1.03 | 1.000 |
| # | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kenneth R. KochMintz Levin Cohn Ferris Glovsky and Popeo | 63 | 100% | 10 | 4.2 | 2.41 | 0.592 | 1.73 | 0.67 | 1.84 |
| 2 | Daniel A. BagliebterMintz Levin Cohn Ferris Glovsky and Popeo | 25 | 96% | 5 | 1.3 | 3.77 | 0.720 | 2.70 | 0.00 | 1.48 |
| 3 | Jeffrey P. SchultzMintz Levin Cohn Ferris Glovsky and Popeo | 46 | 100% | 7 | 2.6 | 2.66 | 0.757 | 2.11 | 0.66 | 1.58 |
| 4 | Megan N. GatesMintz Levin Cohn Ferris Glovsky and Popeo | 43 | 100% | 3 | 3.4 | 0.89 | 1.000 | 0.60 | 0.56 | 1.48 |
| 5 | Jonathan L. KravetzMintz Levin Cohn Ferris Glovsky and Popeo | 35 | 94% | 1 | 3.7 | 0.27 | 1.000 | 0.20 | 0.00 | 1.12 |
| 6 | William C. HicksMintz Levin Cohn Ferris Glovsky and Popeo | 33 | 61% | 1 | 1.9 | 0.53 | 1.000 | 0.40 | 0.00 | 0.93 |
| 7 | Ivan K. BlumenthalMintz Levin Cohn Ferris Glovsky and Popeo | 29 | 66% | 3 | 1.7 | 1.76 | 1.000 | 1.30 | 0.00 | 1.56 |
| 8 | Matthew J. GardellaMintz Levin Cohn Ferris Glovsky and Popeo | 27 | 100% | 3 | 2.2 | 1.37 | 1.000 | 0.85 | 0.00 | 0.60 |
| 9 | William T. WhelanMintz Levin Cohn Ferris Glovsky and Popeo | 19 | 100% | 1 | 1.6 | 0.62 | 1.000 | 0.45 | 0.00 | 1.08 |
| 10 | Lewis J. GeffenMintz Levin Cohn Ferris Glovsky and Popeo | 17 | 71% | 2 | 1.1 | 1.89 | 1.000 | 1.30 | 0.00 | 1.04 |
| 11 | Joel I. PapernikMintz Levin Cohn Ferris Glovsky and Popeo | 14 | 64% | 1 | 1.3 | 0.78 | 1.000 | 0.61 | 2.46 | 1.32 |
| 12 | Melissa V. FrayerMintz Levin Cohn Ferris Glovsky and Popeo | 14 | 93% | 2 | 0.7 | 3.09 | 1.000 | 2.23 | 0.00 | 1.34 |
| 13 | Scott A. SamuelsMintz Levin Cohn Ferris Glovsky and Popeo | 12 | 92% | 1 | 1.6 | 0.63 | 1.000 | 0.39 | 0.00 | 1.28 |
| 14 | Matthew W. TikonoffMintz Levin Cohn Ferris Glovsky and Popeo | 8 | 100% | 1 | 0.4 | 2.71 | 1.000 | 1.85 | 0.00 | 0.66 |
| 15 | Garrett M. WinslowMintz Levin Cohn Ferris Glovsky and Popeo | 7 | 71% | 1 | 0.4 | 2.45 | 1.000 | 1.67 | 0.00 | 1.21 |
| 16 | Thomas R. Burton IIIMintz Levin Cohn Ferris Glovsky and Popeo | 5 | 100% | 1 | 0.4 | 2.66 | 1.000 | 1.91 | 0.00 | 3.15 |
| 17 | John T. RudyMintz Levin Cohn Ferris Glovsky and Popeo | 33 | 58% | 0 | 1.4 | 0.00 | — | 0.00 | 0.00 | 0.82 |
| 18 | Michael L. FantozziMintz Levin Cohn Ferris Glovsky and Popeo | 24 | 96% | 0 | 2.7 | 0.00 | — | 0.70 | 0.00 | 0.88 |
| 19 | Brian P. KeaneMintz Levin Cohn Ferris Glovsky and Popeo | 18 | 94% | 0 | 1.8 | 0.00 | — | 0.00 | 0.00 | 1.26 |
| 20 | Daniel T. KajunskiMintz Levin Cohn Ferris Glovsky and Popeo | 17 | 77% | 0 | 1.5 | 0.00 | — | 0.00 | 0.00 | 0.99 |
| 21 | Jeffrey D. CohanMintz Levin Cohn Ferris Glovsky and Popeo | 14 | 79% | 0 | 0.5 | 0.00 | — | 0.00 | 0.00 | 0.44 |
| 22 | Melanie Ruthrauff LevyMintz Levin Cohn Ferris Glovsky and Popeo | 14 | 100% | 0 | 0.5 | 0.00 | — | 1.31 | 0.00 | 0.85 |
| 23 | Adam C. LenainMintz Levin Cohn Ferris Glovsky and Popeo | 12 | 92% | 0 | 1.1 | 0.00 | — | 0.00 | 0.00 | 0.87 |
| 24 | Jason S. McCaffreyMintz Levin Cohn Ferris Glovsky and Popeo | 12 | 100% | 0 | 0.6 | 0.00 | — | 0.00 | 0.00 | 0.99 |
| 25 | Jeffrey M. WiesenMintz Levin Cohn Ferris Glovsky and Popeo | 12 | 33% | 0 | 1.8 | 0.00 | — | 0.00 | 0.00 | 1.18 |
| 26 | John P. CondonMintz Levin Cohn Ferris Glovsky and Popeo | 12 | 100% | 0 | 1.0 | 0.00 | — | 0.00 | 0.00 | 1.42 |
| 27 | Daniel H. FollansbeeMintz Levin Cohn Ferris Glovsky and Popeo | 9 | 89% | 0 | 1.1 | 0.00 | — | 0.00 | 0.00 | 0.51 |
| 28 | Edwin C. PeaseMintz Levin Cohn Ferris Glovsky and Popeo | 9 | 56% | 0 | 0.5 | 0.00 | — | 0.00 | 0.00 | 0.48 |
| 29 | Marc D. MantellMintz Levin Cohn Ferris Glovsky and Popeo | 9 | 67% | 0 | 0.6 | 0.00 | — | 0.00 | 0.00 | 1.86 |
| 30 | Melanie RuthrauffMintz Levin Cohn Ferris Glovsky and Popeo | 9 | 11% | 0 | 0.5 | 0.00 | — | 1.43 | 0.00 | 0.93 |
| 31 | PETER S. LAWRENCEMintz Levin Cohn Ferris Glovsky and Popeo | 8 | 88% | 0 | 0.6 | 0.00 | — | 0.00 | 0.00 | 1.74 |
| 32 | Jeffrey P. RiedlerMintz Levin Cohn Ferris Glovsky and Popeo | 7 | 100% | 0 | 0.9 | 0.00 | — | 0.71 | 0.00 | 0.56 |
| 33 | John J. CheneyMintz Levin Cohn Ferris Glovsky and Popeo | 7 | 29% | 0 | 0.7 | 0.00 | — | 0.00 | 0.00 | 1.38 |
| 34 | Mark ChamberlinMintz Levin Cohn Ferris Glovsky and Popeo | 7 | 57% | 0 | 0.9 | 0.00 | — | 0.77 | 0.00 | 1.23 |
| 35 | NEIL H. ARONSON UIREMintz Levin Cohn Ferris Glovsky and Popeo | 6 | 100% | 0 | 0.4 | 0.00 | — | 1.63 | 0.00 | 2.41 |
| 36 | Allyson WilkinsonMintz Levin Cohn Ferris Glovsky and Popeo | 5 | 100% | 0 | 0.2 | 0.00 | — | 0.00 | 0.00 | 0.43 |
| 37 | Austin StephensonMintz Levin Cohn Ferris Glovsky and Popeo | 5 | 40% | 0 | 0.5 | 0.00 | — | 0.00 | 0.00 | 1.31 |
| 38 | Daniel I. DeWolfMintz Levin Cohn Ferris Glovsky and Popeo | 5 | 60% | 0 | 0.3 | 0.00 | — | 0.00 | 1.67 | 2.35 |
| 39 | Linda RockettMintz Levin Cohn Ferris Glovsky and Popeo | 5 | 80% | 0 | 0.4 | 0.00 | — | 0.00 | 0.00 | 2.59 |
| 40 | Pamela B. GreeneMintz Levin Cohn Ferris Glovsky and Popeo | 5 | 100% | 0 | 0.3 | 0.00 | — | 0.00 | 0.00 | 2.28 |
| 41 | Stephanie LeopoldMintz Levin Cohn Ferris Glovsky and Popeo | 5 | 100% | 0 | 0.2 | 0.00 | — | 0.00 | 0.00 | 1.25 |
| How it is known | |||
|---|---|---|---|
| Energy XXI LtdEXXIQ (last ticker on record) | Oct 2006 | Text search only |
|
| BIORA THERAPEUTICS, INC.BIOR (last ticker on record) | Jun 2020 | Text search only |
|
| CSC HOLDINGS LLCCVC (last ticker on record) | Sep 1995 | Named in a filing |
|
| ATHENAHEALTH INCATHN (last ticker on record) | Jul 2007 | Text search only |
|
| AVEO PHARMACEUTICALS, INC.AVEO (last ticker on record) | Dec 2009 | Text search only |
|
| ELECTRO SCIENTIFIC INDUSTRIES INCESIO (last ticker on record) | Mar 2002 | Named in a filing |
|
| EXAGEN INC.XGN (last ticker on record) | May 2022 | Named in SEC correspondence |
|
| Happen, Inc.HAPN (last ticker on record) | Aug 2014 | Text search only |
|
| IMMUNE PHARMACEUTICALS INCIMNPQ (last ticker on record) | Apr 2014 | Named in SEC correspondence |
|
| POLARITYTE, INC.PTE (last ticker on record) | May 2004 | Named in SEC correspondence |
|
| RESPONSE GENETICS INCRGDX (last ticker on record) | Dec 2006 | Named in SEC correspondence |
|
| Spero Therapeutics, Inc.SPRO (last ticker on record) | Aug 2017 | Named in SEC correspondence |
|
| SPRUCE POWER HOLDING CORPSPRU (last ticker on record) | Oct 2020 | Named in SEC correspondence |
|
| Tempest Therapeutics, Inc.TPST (last ticker on record) | May 2013 | Named in SEC correspondence |
|
| Tingo Group, Inc.TIO (last ticker on record) | Nov 2018 | Named in SEC correspondence |
|
| Akari Therapeutics PlcAKTX (last ticker on record) | Jul 2012 | Named in SEC correspondence |
|
| CABLEVISION SYSTEMS CORP /NYCVC (last ticker on record) | Oct 2001 | Text search only |
|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL (last ticker on record) | Feb 2001 | Text search only |
|
| COWEN INC.COWN (last ticker on record) | Dec 2009 | Text search only |
|
| CVS HEALTH CorpCVS (last ticker on record) | Dec 2006 | Text search only |
|
| GENZYME CORPGENZ (last ticker on record) | Nov 2000 | Named in a filing |
|
| Harbor Custom Development, Inc.HCDI (last ticker on record) | Jan 2020 | Named in SEC correspondence |
|
| IndiePub Entertainment, Inc.IPUB (last ticker on record) | Dec 2009 | Named in SEC correspondence |
|
| INTERCEPT PHARMACEUTICALS, INC.ICPT (last ticker on record) | Jul 2012 | Named in SEC correspondence |
|
| Ontrak, Inc.OTRK (last ticker on record) | Apr 2011 | Named in SEC correspondence |
|
| PLATINUM ENERGY RESOURCES INCPGRI (last ticker on record) | Jun 2005 | Named in SEC correspondence |
|
| Teligent, Inc.TLGT (last ticker on record) | Mar 2013 | Named in SEC correspondence |
|
| Youngevity International, Inc.YGYI (last ticker on record) | Feb 2013 | Text search only |
|
| Adverum Biotechnologies, Inc.ADVM (last ticker on record) | Aug 2017 | Text search only |
|
| Alphatec Holdings, Inc.ATEC (last ticker on record) | Feb 2006 | Named in SEC correspondence |
|
| AMERICA ONLINE LATIN AMERICA INCAOLA (last ticker on record) | Jan 2000 | Named in a filing |
|
| Butterfly Network, Inc.BFLY (last ticker on record) | Nov 2020 | Named in SEC correspondence |
|
| Codiak BioSciences, Inc.CDAK (last ticker on record) | Aug 2020 | Named in SEC correspondence |
|
| CURAGEN CORPCRGN (last ticker on record) | Oct 1997 | Named in SEC correspondence |
|
| DermTech, Inc.DMTK (last ticker on record) | Jun 2019 | Named in SEC correspondence |
|
| DSS, INC.DSS (last ticker on record) | Nov 2012 | Named in SEC correspondence |
|
| Eiger BioPharmaceuticals, Inc.EIGR (last ticker on record) | Sep 2013 | Text search only |
|
| EPIRUS Biopharmaceuticals, Inc.EPRS (last ticker on record) | Jul 2015 | Named in SEC correspondence |
|
| EPIX Pharmaceuticals, Inc.EPIX (last ticker on record) | Jun 1998 | Named in SEC correspondence |
|
| INTERLEUKIN GENETICS INCILIU (last ticker on record) | Nov 2002 | Named in SEC correspondence |
|
| IVERIC bio, Inc.ISEE (last ticker on record) | Jul 2013 | Text search only |
|
| JAMBA, INC.JMBA (last ticker on record) | Feb 2005 | Named in SEC correspondence |
|
| KING PHARMACEUTICALS INCKG (last ticker on record) | Sep 2005 | Named in SEC correspondence |
|
| Molecular Templates, Inc.MTEM (last ticker on record) | May 2017 | Named in SEC correspondence |
|
| NephroGenex, Inc.NRX (last ticker on record) | Nov 2013 | Named in SEC correspondence |
|
| OFFICE PROPERTIES INCOME TRUSTOPI (last ticker on record) | Oct 2018 | Text search only |
|
| OPTICARE HEALTH SYSTEMS INCOPT (last ticker on record) | Apr 2003 | Named in a filing |
|
| ORCHID CELLMARK INCORCH (last ticker on record) | Feb 2000 | Named in SEC correspondence |
|
| Petros Pharmaceuticals, Inc.PTPI (last ticker on record) | Jul 2020 | Named in SEC correspondence |
|
| Quanterix CorpQTRX (last ticker on record) | Jul 2017 | Named in SEC correspondence |
|